Comparative Study of Xenobiotic-Free Media for the Cultivation of Human Limbal Epithelial Stem/Progenitor Cells. by González, Sheyla et al.
UCLA
UCLA Previously Published Works
Title
Comparative Study of Xenobiotic-Free Media for the Cultivation of Human Limbal Epithelial 
Stem/Progenitor Cells.
Permalink
https://escholarship.org/uc/item/78h427rp
Journal
Tissue engineering. Part C, Methods, 23(4)
ISSN
1937-3384
Authors
González, Sheyla
Chen, Luxia
Deng, Sophie X
Publication Date
2017-04-01
DOI
10.1089/ten.tec.2016.0388
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
METHODS ARTICLE
Comparative Study of Xenobiotic-Free Media
for the Cultivation of Human Limbal Epithelial
Stem/Progenitor Cells
Sheyla Gonza´lez, PhD,1 Luxia Chen, MD, PhD,1,2 and Sophie X. Deng, MD, PhD1
The culture of human limbal epithelial stem/progenitor cells (LSCs) in the presence of animal components poses
the risk of cross-species contamination in clinical applications. We quantitatively compared different xenobiotic-
free culture media for the cultivation of human LSCs. LSCs were cultured from 2· 2mm limbal tissue explants on
denuded human amniotic membrane with different xenobiotic-free culture media: CnT-Prime (CnT-PR) sup-
plemented with 0%, 1%, 5%, and 10% human serum (HS), embryonic stem cell medium (ESCM) alone or in
combination with the standard supplemented hormonal epithelium medium (SHEM, control) at a 1:1 dilution
ratio, and modified SHEM (mSHEM), in which cholera toxin and dimethyl sulfoxide (DMSO) were removed,
isoproterenol was added, and the epidermal growth factor concentration was reduced. Several parameters were
quantified to assess the LSC phenotype: cell morphology, cell growth, cell size, outgrowth size, and expression
of the undifferentiated LSC markers cytokeratin (K) 14, and p63a high-expressing (p63abright) cells, a mature
keratinocyte marker K12, epithelial marker pancytokeratin (PanK), and stromal cell marker vimentin (Vim).
Compared with the standard SHEM control, CnT-PR base medium was associated with a lower cell growth and
reduction in the proportion of stem cells generated regardless of the amount of HS supplemented ( p< 0.05);
ESCM resulted in an increased proportion of PanK-/Vim+ stromal cells ( p< 0.05) and a decreased proportion of
p63abright cells ( p< 0.05); mSHEM supported a similar cell growth ( p> 0.05), increased the number of small cells
(diameter £12mm; p< 0.05), and provided a similar proportion of p63abright cells ( p> 0.05). Among all the
conditions tested, mSHEM was the most efficient and consistent in supporting the LSC phenotype and growth.
Keywords: limbal epithelial stem cells, limbal stem cell deficiency, limbal stem cell therapy, isoproterenol,
CnT-Prime, embryonic stem cell medium, SHEM, xenobiotic-free
Introduction
L imbal stem cell deficiency (LSCD) is a cornealdisorder, in which limbal epithelial stem/progenitor
cells (LSCs) are absent or dysfunctional and, consequently,
the ability to regenerate a corneal epithelial surface is lost.
LSCD is characterized by persistent epithelial defects,
conjunctivalization, neovascularization, scarring, and in-
flammation, all of which lead to corneal opacity, pain,
photophobia, and ultimately blindness.
Corneal transplantation is ineffective to treat severe to
total LSCD because functional LSCs are not transplanted.
The highest success rate treating LSCD was achieved by
using cultivated LSCs that were expanded from single LSCs
cultured on 3T3 mouse fibroblasts feeder layers in culture
medium that contained fetal bovine serum (FBS).1 However,
the presence of animal components in the culture system
posed the risk of transmitting animal diseases to human
recipients of these LSCs.
Different formulations of xenobiotic-free culture media
that can sustain the growth of LSCs in vitro have been used,
but their clinical success rates were reported to be lower
than that using 3T3 feeder cells and bovine fetal serum.2–5
For instance, transplantation of cultivated LSCs under
xenobiotic-free explant culture supplemented with autolo-
gous serum achieved 71% clinical success.2 Anatomical
1Stein Eye Institute, University of California, Los Angeles, California.
2Tianjin Eye Hospital and Eye Institute, Tianjin, China.
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restoration of a corneal epithelial surface was achieved
in 67% of patients who received cultivated LSCs using
CnT-Prime (CnT-PR) medium (formerly CnT-20) supple-
mented with human serum (HS) in a Phase I/II trial.4,5
Embryonic stem cell medium (ESCM) supplemented with
KnockOut Serum Replacement has also been used to culture
LSCs in vitro.6 FBS from supplemented hormonal epithelium
medium (SHEM) has been replaced by KnockOut Serum Re-
placement in the LSC culture.7 Also, SHEM has been further
modified to replace cholera toxin with isoproterenol in vitro.8
However, the efficiency of these different xenobiotic-free
media in supporting the expansion of LSCs has not been
compared directly using the same criteria.
It has been shown that the percentage of p63a high-
expressing (p63abright) cells correlated with clinical suc-
cess.1 In the present study, we investigated the efficiency
of different xenobiotic-free culture media, with measures of
efficiency defined as cell growth and the relative amount of
stem/progenitor cells, including p63abright cells, generated in
each culture medium.
Materials and Methods
Limbal epithelial stem cell culture
The study was exempted by the University of California
Los Angeles Institutional Review Board (IRB No. 11-003284
and IRB No. 12-000363). Human sclerocorneal tissues from
40- to 70-year-old donors were obtained from eye banks and
handled in accordance with the tenets of the Declaration of
Helsinki. The tissues were preserved in Optisol (Chiron
Ophthalmics, Inc., Irvine, CA) or Life4C (Numedis, Inc.,
Isanti, MN) at 4C. The death-to-preservation time was less
than 12 h, and the death-to-experiment time was less than
7 days. Amniotic membrane (AM) was selected as the culture
substrate. Epithelial cells from the AM were mechanically
removed as previously described9 in an EDTA solution
(Versene; Life Technologies, Carlsbad, CA).
To isolate limbal epithelial cell sheets, the iris, endothe-
lium, conjunctiva, and Tenon’s capsule were removed from
the sclerocorneal rim tissue. The rim was incubated in 2.4U/
mL of dispase II (Roche, Indianapolis, IN) at 37C for 2 h in
Dulbecco’s Modified Eagle’s Medium (DMEM)/F-12
(Ham) medium (Life Technologies) followed by a gentle
scrapping under the dissecting microscope. Single cells were
obtained by incubation in 0.25% trypsin-EDTA (Life
Technologies) for 5min. Explant tissue pieces (dimensions,
2 · 2mm) were also obtained from the limbal area. Ex-
periments were performed with three to six sclerolimbal
donor tissues. LSCs were cultured by using limbal explants
placed on denuded AM in different culture media (Table 1).
CnT-PR (CELLnTEC, Switzerland) was tested in the ab-
sence (CnT-PR 0) or presence of human serum (HS) (In-
novative Research, Novi, MI); the concentrations of HS that
were tested were 1% (CnT-PR 1), 5% (CnT-PR 5), and 10%
(CnT-PR 10; Table 1). ESCM 1 was prepared as previously
described6 with KnockOut DMEM (Life Technologies)
supplemented with 10%KnockOut SerumReplacement (Life
Technologies), 1% (v/v) N2 supplement (Life Technologies),
4 ng/mL of basic fibroblast growth factor (Life Technolo-
gies), 1mM l-glutamine, 0.1mM b-mercaptoethanol (Life
Technologies), and 1% (v/v) nonessential amino acids (Life
Technologies). ESCM 2, which consisted of ESCM and
SHEM at a 1:1 ratio (Table 1), was also tested.
The standard SHEM was prepared as previously de-
scribed10 and used as a control medium. In brief, SHEM
consisted of DMEM/F-12 medium supplemented with 5%
HS, 1% (v/v) N2 supplement, 2.0 ng/mL of epidermal
growth factor (EGF; Life Technologies), 8.4 ng/mL of
cholera toxin (Sigma-Aldrich, St. Louis, MO), 0.5 mg/mL of
hydrocortisone (Sigma-Aldrich), and 0.5% (v/v) of dimethyl
sulfoxide (DMSO; Sigma-Aldrich).
Several modifications were made to SHEM (Tables 1 and
2): SHEM 1 was supplemented with 5% HS, and both
cholera toxin and DMSO were not added to the medium. In
SHEM 2, HS was increased to 10%. In SHEM 3, cholera
toxin was replaced by isoproterenol8 (Sigma-Aldrich); the
final concentration of isoproterenol was 1 mg/mL. In SHEM
Table 1. Media Conditions Tested
Media conditions
CnT-PR (Explant), n = 4 ESCM (Explant), n = 6 SHEM (Explant), n = 3
CnT-PR 0 (CnT-PR w/o HS) ESCM 1 (ESCM) SHEM 1 (SHEM-Chol-DMSO)
CnT-PR 1 (CnT-PR 1%HS) ESCM 2 (SHEM:ESCM) SHEM 2 (SHEM10-Chol-DMSO)
CnT-PR 5 (CnT-PR 5%HS) SHEM 3 (SHEM-Chol-DMSO+Ipr)
CnT-PR 10 (CnT-PR 10%HS) SHEM 4 (SHEM-Chol+DMSO+Ipr)
SHEM 5 (SHEM-Chol-DMSO+Ipr+1XEGF)
3T3 SHEM Cntl
Explant SHEM Cntl
Italics are the most efficient culture media for the growth of the LSCs.
Chol, cholera toxin; Cntl, control; CnT-PR, CnT-Prime, epithelial culture medium; DMSO, dimethyl sulfoxide; EGF, epithermal growth
factor; ESCM, embryonic stem cell medium; Expl, explant; HS, human serum; Ipr, isoproterenol/Isuprel; LSCs, limbal epithelial stem/
progenitor cells; SHEM, supplemented hormonal epithelium medium.
Table 2. SHEM Media Composition
HS (%)
EGF
(ng/mL) DMSO Chol Ipr
Explant SHEM Cntl 5 2.0 Yes Yes No
SHEM 1 5 2.0 No No No
SHEM 2 10 2.0 No No No
SHEM 3 5 2.0 No No Yes
SHEM 4 5 2.0 Yes No Yes
SHEM 5 5 0.4 No No Yes
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4, DMSO and isoproterenol were added to the medium, but
cholera toxin was not. Finally, in SHEM 5, the concentra-
tion of EGF was reduced to 0.4 ng/mL; the rest of the
components and their concentrations were the same as those
in SHEM 3.
Single LSCs on growth-arrested 3T3 mouse fibroblasts
(the Howard Green laboratory, Harvard Medical School)
cultured in the standard unmodified SHEM with 5% FBS
(Life Technologies) served as the control (3T3 SHEM Cntl)
for all tissue donors tested. Explants on denuded AM (Ex-
plant SHEM Cntl) cultured in unmodified SHEM with 5%
HS also served as another control of the LSC growth
(Table 1). LSCs were cultured at 37C with 5% CO2 for up
to 14 days. The medium was changed every 2–3 days.
Analysis of cell growth, cell size, cell morphology,
and transplantability of outgrowths
Cell growth from a single explant tissue piece was cal-
culated by counting the total number of cells harvested once
the cells have been detached from the AM after dispase/
trypsin-EDTA treatment.
Cell size was measured by ImageJ software (Colony
Counter plugin). The percentage of cells whose diameter
was £12 mm (small cells) was calculated for each culture
condition.
Cell morphology of the outgrowths was assessed by using
an inverted DMIL LED microscope (Leica Microsystems,
Wetzlar, Germany). Cell images were taken with an Insight
11.2 color mosaic digital camera (Spot Imaging Solutions,
Sterling Heights, Michigan). The outgrowth shape and size
were measured; an outgrowth that was at least 13mm in its
smallest diameter after 10–14 days in culture was consid-
ered to be transplantable.
Immunocytochemistry
Cultured LSCs were treated with trypsin to generate a
single-cell suspension that was subjected to cytocen-
trifugation (Cytofuge; Thermo Scientific, Waltham, MA)
onto glass slides (Fisher Scientific, Canoga Park, CA), and
stored at -20C. Cells were fixed in a 4% paraformaldehyde
solution (Electron Microscopy Sciences, Hatfield, PA).
Blocking and permeabilization were performed in a solution
of 1% bovine serum albumin (Sigma-Aldrich) and 0.5%
Triton X-100 (Sigma-Aldrich) for 30min. Primary antibody
incubation was done in a solution of 1% bovine serum al-
bumin and 0.1% Triton X-100, overnight at 4C (antibodies
are listed in Table 3). Secondary antibody incubation was
done at room temperature for 1 h. Nuclei were stained with
Hoechst 33342 (Life Technologies) at room temperature for
10min. Mounting was done with Fluoromount medium
(Sigma-Aldrich). Pictures were taken with a Zeiss Im-
ager.A2 fluorescent microscope (Carl Zeiss, Inc., Oberko-
chen, Germany) equipped with an Insight 11.2 color mosaic
digital camera.
Cells that expressed high levels of p63a (p63abright cells)
were quantified by using the Definiens Tissue Studio soft-
ware (Larchmont, NY) as previously reported.11 Quantita-
tion of cells that expressed cytokeratin (K) 14, K12,
pancytokeratin (PanK), or vimentin (Vim) was performed
using ImageJ software.
Statistical analysis
Data were analyzed with the pairwise t-test. In the graphs,
bars indicate the mean – standard error of the mean (SEM).
p Values <0.05 indicate statistical significance.
Results
Efficiency of three different base media
in supporting LSC growth
We first investigated the optimal formulation for each of
the three base media: CnT-PR, ESCM, and SHEM
(Figs. 1–3 and Tables 1–2). After the optimal formulation of
each base medium was determined, all three base media
were compared to determine which one sustained the most
efficient LSC growth (Figs. 4 and 5 and Table 4).
Outgrowths of undifferentiated LSCs contained small and
cuboidal epithelial-like cells in the control cultures: 3T3
SHEM Cntl and Explant SHEM Cntl (Fig. 1A). LSC cultures
in CnT-PR medium supplemented with different concentra-
tions of HS showed variable and inconsistent results (Fig. 1).
LSCs cultured in CnT-PR exhibited heterogeneous mor-
phology; in some cases, the cells were spindle shaped. A large
quantity of floating dead cells and loose cell sheets at the edge
was present. The increased concentration of HS in CnT-PR 5
appeared to reduce the quantity of floating dead cells and led
to a more compact LSC morphology (Fig. 1A). The cell ex-
pansion rate was significantly reduced in all CnT-PR condi-
tions ( p < 0.05), but the cell expansion rate in the CnT-PR
culture with 10%HS ( p = 0.05) was comparable to that of the
explant SHEM Cntl in unmodified SHEM (Fig. 1B).
Analysis of the cell phenotype and quantitation of small
cells (Fig. 1C) revealed that CnT-PR 5 was the most efficient
of the CnT-PR-based media to culture LSCs. Compared with
the explant SHEM Cntl, the culture grown in CnT-PR 5
produced a similar proportion of small cells (£12 mm;
3.5%– 1.0% in the control vs 3.9%– 1.7%, p = 0.84), a small
proportion of differentiated K12+ cells (1.5% – 0.4% in the
control vs 2.7% – 1.1%, p = 0.19), a high proportion of PanK+
epithelial cells (98.8%– 0.4% in the control vs 96.9%– 0.9%,
p = 0.78), and a similar proportion of Vim+ stromal cells
(1.1%– 0.2% in the control vs 1%– 0.5%, p= 0.50). The
percentage of p63abright cells, which has been previously
positively correlated with the transplantation success,1 was
the highest in CnT-PR 5 among all CnT-PR conditions tested
( p< 0.05) and statistically comparable to the explant SHEM
Cntl (17.8% – 5.7% vs 27.6%– 5.2%, respectively, p= 0.25).
Table 3. Primary Antibodies Used
for Immunocytochemistry
Primary
antibody Dilution Source (catalogue no.)
K12 1:100 Santa Cruz Biotechnology (sc-25722)
K14 1:50 Fisher Scientific (MS-115-R7)
p63a 1:100 Cell Signaling Technology (No. 4892)
PanK 1:100 DAKO (M3515)
Vim 1:100 Abcam (ab92547)
K12, cytokeratin 12; K14, cytokeratin 14; PanK, pancytokeratin;
Vim, vimentin.
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FIG. 1. Morphology (A), cell growth (B), and characterization (C) of LSCs cultured in four different CnT-PR conditions. ‘‘Abs
# cells/explant’’ refers to the absolute number of cells harvested from one explant tissue piece on average. Scale bar 50mm. Two
pictures of each culturemedium condition have been included to showdifferent areas of the outgrowth. *p< 0.05were considered
significant. CnT-PR, CnT-Prime; LSCs, limbal epithelial stem/progenitor cells.
FIG. 2. Morphology (A), cell growth (B), and characterization (C) of LSCs cultured in two different ESCM conditions.
‘‘Abs # cells/explant’’ refers to the absolute number of cells harvested from one explant tissue piece on average. Scale bar
50 mm. *p < 0.05 were considered statistically significant. ESCM, embryonic stem cell medium.
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LSCs cultured in ESCM 1 had a heterogeneous mor-
phology consisting of a mixture of small and cuboidal
epithelial-like and fibroblast-like cells (Fig. 2A). LSC cul-
tures in ESCM 2 shared a similar morphology as did those in
the 3T3 SHEM Cntl and Explant SHEM Cntl (Fig. 2A). The
cell expansion rate in ESCM 1 was significantly lower than
that in the explant SHEM Cntl (49.7% slower in ESMC 1,
p = 0.01; Fig. 2B). In contrast to ESCM 1, ESCM 2 in-
creased the LSC growth to a similar degree as in the explant
SHEM Cntl ( p = 0.81; Fig. 2B).
ESCM 1 increased the proportion of Vim+ stromal cells
(1.8% – 0.6% vs 0.2% – 0.1% in the explant SHEM Cntl,
p = 0.04) and the percentage of small cells (8.4%– 2.2% vs
3.3% – 0.9% in the explant SHEM Cntl, p = 0.04) and de-
creased the percentage of p63abright cells (4.4%– 1.3% vs
20.3% – 5.7%, p= 0.04; Fig. 2C). Compared with the ex-
plant SHEM Cntl, ESCM 2 provided a statistically similar
percentage of Vim+ cells (1.6% – 0.8%, p = 0.16), K12+ cells
(1.8% – 0.6%, p = 0.06), and p63abright cells (6.7% – 3.6%,
p = 0.06; Fig. 2C).
When SHEM was modified, the substitution of cholera
toxin by isoproterenol in the absence of DMSO (SHEM 3
and SHEM 5) improved the cell sheet quality by reducing
the amount of floating dead cells and the heterogeneous
morphology seen in cultures grown in other SHEM formu-
lations. Cultures in the presence of SHEM 5, with a reduced
concentration of EGF, maintained the limbal epithelial
morphology (Fig. 3A). The cell expansion rate was signifi-
cantly reduced in most of the modified SHEM (mSHEM)
formulations ( p < 0.05) except SHEM 3 and SHEM 5, in
which cholera toxin and DMSO were replaced by isopro-
terenol (both p ‡ 0.05; Fig. 3B).
LSCs cultured in SHEM 3 and SHEM 5 showed a phe-
notype similar to that of cells grown in the explant SHEM
Cntl in terms of the percentage of small cells, p63abright
cells, K12+ cells, and Vim+ stromal cells (all p> 0.05;
Fig. 3C). However, other modifications of SHEM resulted in
either a significant increase in the proportion of K12+ cells
or Vim+ cells, or a decrease in the percentage of p63abright
cells. Therefore, SHEM 5 appeared to be the best formula-
tion among all 5 SHEM-based media.
Growth of LSCs in the different optimized base media
As shown above, CnT-PR 5, ESCM 2, and SHEM 5 were
the most efficient culture media for the growth of LSCs
(Table 1, italics). These conditions were compared in a
second set of experiments and will be referred to as CnT-
PR, ESCM, and mSHEM, respectively, for simplicity in the
rest of the article (Figures 4 and 5 and Table 4). Explant
culture using the standard SHEM served as the control in
these experiments and therefore will be referred to as the
control.
We found that mSHEM supported the most compact and
homogeneous cell outgrowths that contained small and cu-
boidal limbal epithelial-like cells (Fig. 4A). LSC cultures in
CnT-PR and ESCM tended to be slightly more heteroge-
neous and variable (Fig. 4A).
ESCM and mSHEM supported the LSC growth similar to
that of the explant SHEM Cntl ( p > 0.05; Fig. 4B). How-
ever, the LSC growth in CnT-PR was 76.6% reduced
compared with the explant SHEM Cntl ( p= 0.03; Fig. 4B).
A higher percentage of small cells (£12mm) was found in
the mSHEM cultures than in other conditions, including
explant SHEM Cntl (7.8%– 3.4% vs 3.5% – 0.1%, respec-
tively, p = 0.04; Fig. 4C). Both CnT-PR and ESCM were
able to produce a similar percentage of small cells as the
explant SHEM Cntl (3.9% – 1.7% and 2.8% – 0.6%, re-
spectively; both p> 0.05; Fig. 4C).
LSC outgrowths generated in each culture condition were
classified as transplantable/nontransplantable on the basis of
the size and shape of the cell sheet. Outgrowths that mea-
sured at least 13mm in their smallest diameter were con-
sidered transplantable (Table 4). Cells grown in CnT-PR
produced the smallest outgrowths and the smallest relative
quantity of transplantable cell sheets (33.3% vs 94.1% in the
control, p = 0.02; Table 4). In the ESCM cultures, the out-
growths were larger, and 62.5% were considered trans-
plantable ( p = 0.03; Table 4). In comparison with ESCM
and CnT-PR, mSHEM produced the most homogeneous
outgrowths, and 100% were considered to be transplantable.
On average, both diameters of cell outgrowths in mSHEM
exceeded the 13-mm requirement (Table 4).
We next characterized the cell population in the cultures.
The expression of K14 and K12 protein was analyzed to
distinguish the proportion of undifferentiated corneal epi-
thelial cells from the differentiated ones. Outgrowths from
FIG. 4. Cell morphology (A), cell growth (B), and per-
centage of small cells (£12 mm) (C) among LSCs cultured in
each base medium: CnT-PR, ESCM, and mSHEM. ‘‘Abs #
cells/explant’’ refers to the absolute number of cells har-
vested from one explant tissue piece on average. Scale bar
50 mm. *p < 0.05 were considered significant.
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all three conditions contained a similar percentage of K14+
cells, which was >95% ( p > 0.05; Fig. 5A, D). Only cultures
grown in mSHEM contained a significantly smaller pro-
portion of differentiated K12+ cells (1.3%– 0.5% vs
2.5%– 1.2% in the control, p = 0.01). Cultures grown in
CnT-PR contained 2.7% – 1.1% K12+ cells, and cultures
grown in ESCM contained 1.8%– 0.6% K12+ cells
( p> 0.05; Fig. 5A, D). Overall, such small proportions of
differentiated K12+ cells are not clinically significant.
We measured the percentage of p63abright cells in the
cultures as a potential indication of the LSC transplantation
success.1 Cultures grown in CnT-PR and mSHEM contained
FIG. 5. Characterization of LSCs cultured in CnT-PR, ESCM, and mSHEM. Representative images of double immunostaining
for the detection ofK14-K12 (A), p63a (B), andPanK-Vim (C). Scale bar 50mm.Percentage ofK14+/K12+ cells (D), p63abright cells
(E), and PanK+/Vim+ cells (F). *p< 0.05 were considered significant. Color images available online at www.liebertpub.com/tec
Table 4. Size and Transplantability
of the Outgrowths in the Different
Media Conditions
Major
diameter
(mm)
Minor
diameter
(mm)
Transplantable
outgrowths (%)
Control 26.9 – 3.9 21.4– 1.7 94.1
CnT-PR 13.5 – 3.2 11.0– 2.5 33.3
ESCM 27.3 – 2.9 13.2– 2.0 62.5
mSHEM 25.0 – 0.0 23.0– 2.0 100.0
mSHEM, modified SHEM.
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proportions of p63abright cells (17.8%– 5.7% and 16.1% –
0.4%, respectively) similar to those in the explant SHEM
Cntl (22.8% – 2.4%, p > 0.05; Fig. 5B, E). ESCM was the
culture condition that produced the least amount of
p63abright cells (6.7%– 3.6%, p = 0.04; Fig. 5B, E).
The expression of PanK and Vim proteins was examined
to determine the proportion of epithelial cells (PanK+/Vim-
and PanK+/Vim+) and stromal cells (PanK-/Vim+) in the
cultures. In general, all the cultures had a high percentage of
either PanK+/Vim- or PanK+/Vim+ cells (>95% in all the
conditions, p > 0.05; Fig. 5C, F). Only the ESCM cultures
contained a proportion of PanK-/Vim+ stromal cells
(1.6% – 0.8%) that was significantly larger than that of the
control (0.6%– 0.3%, p = 0.04).
Discussion
To have a standardized LSC therapy using cultivated
LSCs, there is the need for an optimized and xenobiotic-free
culture system. In the present study, we investigated three
different base culture media in their ability to support the
expansion of LSCs using a standard set of quantifiable cri-
teria. The optimal formulation of each of the three base
medium was determined before these three base media were
directly compared with one another.
CnT-PR appears to be less efficient in supporting the
growth of LSCs in vitro than the standard SHEM. We hy-
pothesized that the LSC growth efficiency could be improved
by supplementing a higher level of HS. We found that CnT-
PR supplemented with 5% HS (CnT-PR 5) was better than
CnT-PR supplemented with 1% HS in maintaining the LSC
phenotype of most LSC cultures. However, the CnT-PR 5
medium was still less efficient than the standard SHEM in
supporting the expansion of the LSC population.
LSCs and limbal stromal niche cells have been cultured as
spheres in three-dimensional (3D) Matrigel using ESCM to
prevent differentiation and to maintain the clonal growth of
LSCs.6 This method was excellent in maintaining the close
association between LSCs and limbal stromal cells, but LSC
proliferation was not optimal.6 This finding is consistent with
our own: when ESCM alone was used, the LSC proliferation
rate was low, and some areas of outgrowth contained spin-
dled, fibroblast-like cells. ESCM may favor the growth of
these fibroblast-like stromal cells over the epithelial cells; this
possibility is supported by the increase in the number of
small, stromal-like PanK-/Vim+ cells. In a three-dimensional
(3D) system such as Matrigel, the association between stro-
mal cells and LSCs helped in the maintenance of LSC phe-
notype, which is similar to the effect of the in vivo niche.6
However, in a 2D system, in which both LSCs and stromal
cells are plated together on a culture dish (e.g., a 2D system
such as an explant culture on AM), there might be competi-
tion for the growth space and growth factors that favor the
growth of stromal cells over the epithelial cells.
The mSHEM without DMSO and cholera toxin provided
the most efficient and consistent growth of LSCs. Cholera
toxin is well known for accelerating the cellular growth rate
of human keratinocytes in culture by increasing the intra-
cellular concentration of cyclic AMP; this intracellular
second signaling messenger regulates cell proliferation.12
However, cholera toxin is obtained from bacteria and
manufactured using animal components; moreover, it has
been reported to have side effects in humans.13 Iso-
proterenol is a nonselective beta-adrenergic agonist that has
been previously shown, at a concentration of 1 mg/mL, to
efficiently replace cholera toxin and thus enhance cell pro-
liferation.8 DMSO enhances the permeability of the lipid
cell membranes during the cell culture period14; however,
when DMSO has been included in stem cell cultures used
for bone marrow stem cell transplantation, there have been
reports of toxic side effects such as cardiovascular and re-
spiratory issues due to DMSOs dose-dependent vasocon-
strictor effect.15 To minimize the potential toxicity of
DMSO, different cell culture strategies were evaluated;
among all conditions tested, the removal of DMSO in
combination with the addition of isoproterenol resulted in
the most efficient LSC growth. This strategy would signify a
safer way to culture the LSCs for future transplantation by
potentially diminishing the potential toxic effects of DMSO
and cholera toxin to the recipient.
EGF appears to have different effects on LSCs in culture.
Some studies have shown the importance of EGF in pro-
moting LSC proliferation16; other studies have found an in-
crease in LSCmotility and a decrease in the induction of K12
expression in the presence of EGF.17 EGF has also been
shown to increase survival and colony-forming efficiency,
but not necessarily the LSC growth rate.18 Moreover, long-
term cultures in the presence of EGF have not survived more
than 3 months.19 When EGF concentration in cultures was
reduced five times from 2.0 to 0.4 ng/mL, we found a more
homogenous LSC-like cell morphology and a slight increase
in the percentages of small cells and p63abright cells without a
significant decrease in the proliferation rate. Therefore, short-
term use of reduced EGF concentrations may favor cell sur-
vival and maintain the same degree of proliferation.
In conclusion, a robust xenobiotic-free culture system that
can consistently support a sufficient expansion and maintain
the undifferentiated state of LSCs is highly desired to
achieve a successful reconstruction of a normal corneal
epithelial surface in eyes with severe or total LSCD. Herein,
we present a comparative analysis on different xenobiotic-
free culture media using a set of quantitative criteria to
standardize the cultivated LSC characterization. A mSHEM-
based xenobiotic-free medium can consistently support LSC
expansion from different limbal donor tissues.
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